🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 13 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/08/2013 | 73,27 | 74,17 | 73,07 | 73,75 | +0,66% | 1,50% | 171.400 |
| 08/08/2013 | 74,14 | 74,14 | 72,87 | 73,27 | -0,26% | 1,71% | 242.000 |
| 07/08/2013 | 73,61 | 74,19 | 73,13 | 73,46 | -0,51% | 1,44% | 375.100 |
| 06/08/2013 | 74,91 | 75,18 | 73,34 | 73,84 | -1,73% | 2,46% | 689.900 |
| 05/08/2013 | 76,93 | 76,95 | 75,01 | 75,14 | -2,02% | 2,52% | 561.700 |
| 02/08/2013 | 75,87 | 76,75 | 75,18 | 76,69 | +1,08% | 2,07% | 428.000 |
| 01/08/2013 | 75,71 | 76,47 | 74,64 | 75,87 | +1,25% | 2,42% | 832.700 |
| 31/07/2013 | 73,90 | 75,37 | 73,34 | 74,93 | +1,60% | 2,75% | 783.900 |
| 30/07/2013 | 72,99 | 74,64 | 72,70 | 73,75 | +1,54% | 2,66% | 964.200 |
| 29/07/2013 | 72,50 | 72,89 | 71,57 | 72,63 | +0,18% | 1,82% | 397.200 |
| 26/07/2013 | 71,50 | 72,67 | 71,12 | 72,50 | +0,93% | 2,17% | 340.300 |
| 25/07/2013 | 73,85 | 74,46 | 70,19 | 71,83 | +1,73% | 5,78% | 905.100 |
| 24/07/2013 | 71,25 | 71,53 | 70,29 | 70,61 | -0,25% | 1,74% | 324.100 |
| 23/07/2013 | 71,30 | 71,38 | 70,25 | 70,79 | -0,60% | 1,58% | 435.600 |
| 22/07/2013 | 70,09 | 71,75 | 70,09 | 71,22 | +1,74% | 2,37% | 494.100 |
| 19/07/2013 | 69,43 | 71,15 | 69,22 | 70,00 | +0,21% | 2,78% | 567.000 |
| 18/07/2013 | 68,51 | 70,00 | 68,18 | 69,85 | +2,30% | 2,66% | 403.700 |
| 17/07/2013 | 68,30 | 68,94 | 67,03 | 68,28 | +0,47% | 2,80% | 869.600 |
| 16/07/2013 | 69,40 | 69,40 | 67,44 | 67,96 | -1,79% | 2,82% | 591.900 |
| 15/07/2013 | 69,37 | 69,68 | 68,14 | 69,20 | +0,17% | 2,22% | 891.600 |
| 12/07/2013 | 67,97 | 69,68 | 67,36 | 69,08 | +1,42% | 3,41% | 1.187.600 |
| 11/07/2013 | 68,85 | 69,00 | 67,22 | 68,11 | +0,40% | 2,59% | 969.800 |
| 10/07/2013 | 67,72 | 68,22 | 67,45 | 67,84 | -0,18% | 1,14% | 506.900 |
| 09/07/2013 | 68,58 | 68,93 | 67,18 | 67,96 | -0,26% | 2,55% | 442.800 |
| 08/07/2013 | 67,58 | 68,24 | 67,26 | 68,14 | +1,38% | 1,45% | 467.700 |
| 05/07/2013 | 66,33 | 67,97 | 66,33 | 67,21 | +1,68% | 2,47% | 340.200 |
| 03/07/2013 | 66,53 | 66,84 | 66,01 | 66,10 | -0,84% | 1,25% | 494.700 |
| 02/07/2013 | 67,80 | 68,30 | 66,58 | 66,66 | -1,43% | 2,54% | 624.600 |
| 01/07/2013 | 66,51 | 69,49 | 66,23 | 67,63 | +2,75% | 4,90% | 821.800 |
| 28/06/2013 | 64,24 | 66,82 | 64,00 | 65,82 | +2,14% | 4,39% | 929.000 |